Alpinetin inhibits lung cancer progression and elevates sensitization drug-resistant lung cancer cells to cis-diammined dichloridoplatium

MLA

Wu L, et al. “Alpinetin Inhibits Lung Cancer Progression and Elevates Sensitization Drug-Resistant Lung Cancer Cells to Cis-Diammined Dichloridoplatium.” Drug Design, Development and Therapy, vol. 2015, no. default, Nov. 2015, pp. 6119–27. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsdoj&AN=edsdoj.18ed12105451447392870662578014e3&authtype=sso&custid=ns315887.

APA

Wu L, Yang W, Zhang SN, & Lu JB. (2015). Alpinetin inhibits lung cancer progression and elevates sensitization drug-resistant lung cancer cells to cis-diammined dichloridoplatium. Drug Design, Development and Therapy, 2015(default), 6119–6127.

Chicago

Wu L, Yang W, Zhang SN, and Lu JB. 2015. “Alpinetin Inhibits Lung Cancer Progression and Elevates Sensitization Drug-Resistant Lung Cancer Cells to Cis-Diammined Dichloridoplatium.” Drug Design, Development and Therapy 2015 (default): 6119–27. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsdoj&AN=edsdoj.18ed12105451447392870662578014e3&authtype=sso&custid=ns315887.